Research on Post-Stroke Anticoagulation Strategies for Atrial Fibrillation Based on Left Atrial Appendage Flow Velocity Measured by Intracardiac Echocardiography (ICE)
1 other identifier
observational
172
1 country
2
Brief Summary
- 1.Study Purpose The primary aim of this research was to systematically describe and characterize a novel, thrombus-mimicking artifact observed during Intracardiac Echocardiography (ICE), termed the "Floating Lotus" sign. The study sought to define its imaging features, determine its prevalence, and identify the clinical factors that predict its occurrence. This was driven by the clinical need to prevent the misdiagnosis of this pseudo-thrombus as a true Left Atrial Appendage (LAA) thrombus, which could lead to unnecessary procedure cancellations or anticoagulation changes.
- 2.Study Population The study population consisted of 172 consecutive patients with non-valvular atrial fibrillation (AF) who underwent ICE-guided catheter ablation and/or left atrial appendage occlusion (LAAO) between January and December 2024 across three tertiary medical centers. Patients with confirmed intracardiac thrombus, significant valvular heart disease, or prior cardiac surgery were excluded.
- 3.Key Research Focus
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedFebruary 27, 2026
December 1, 2025
1 year
February 23, 2026
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of the "Floating Lotus" Sign
Intraoperative
Secondary Outcomes (2)
Independent Predictors of the "Floating Lotus" Sign
Preoperative baseline
Determinants of Left Atrial Appendage (LAA) Emptying Velocity
Intraoperative
Interventions
The core of this procedure is to perform a characteristic catheter operation on the basis of routine ICE scanning of the left atrial appendage: when an unclear, movable, chaotic echogenic mass (suspected thrombus) is observed in the standard plane, the operator needs to slowly and continuously rotate the ICE catheter clockwise. This dynamic maneuver aims to induce morphological changes in the echogenic mass, observe whether it merges with the left atrial appendage wall and reveals the underlying pectinate muscle structure, thereby confirming it as a pericardial effusion-related floating artifact (i.e., the 'Floating Lotus' sign), rather than a true intracavitary thrombus.
Eligibility Criteria
The study population was derived from patients with atrial fibrillation who consecutively underwent intracardiac echocardiography (ICE)-guided catheter ablation and/or left atrial appendage occlusion (LAAO) between January and December 2024 at three tertiary medical centers in China.
You may qualify if:
- Patients with a confirmed diagnosis of non-valvular atrial fibrillation (paroxysmal or persistent).
- Completion of complete intracardiac echocardiography (ICE) imaging during the catheter ablation or left atrial appendage occlusion (LAAO) procedure.
You may not qualify if:
- Confirmed intracardiac thrombus on pre-procedural transesophageal echocardiography (TEE) or left atrial computed tomography angiography (CTA).
- Significant valvular heart disease (moderate or severe stenosis/regurgitation) or a history of cardiac surgery.
- Incomplete clinical or imaging data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Changhai Hospitallead
- Shanghai Shidong Hospital, Yangpu Districtcollaborator
- Eastern Hepatobiliary Surgery Hospitalcollaborator
Study Sites (2)
The First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital)
Shanghai, Shanghai Municipality, 200433, China
Shanghai Shidong Hospital, Yangpu District
Shanghai, Shanghai Municipality, 200438, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2026
First Posted
February 27, 2026
Study Start
January 1, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
February 27, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Available starting 12 months after publication of the primary results, for a duration of 12 months.
- Access Criteria
- Access granted only to qualified researchers upon reasonable request. Only de identified participant-leveldata will be shared. Requests are subject to sponsor approval.
We plan to share fully de-identified individual participant data (IPD) that underlie the results reported in the primary publication of this study. This includes: Baseline demographic and clinical characteristics; Procedural echocardiographic parameters ; These data will be made available upon reasonable request to researchers whose proposed use has been approved by an independent review committee for legitimate scientific purposes. Data will be shared after the publication of the primary results, typically within 12 months. Data access requires a signed data use agreement to ensure compliance with ethical and privacy regulations.